Mail

UK markets closed

FTSE 100
8,146.86
-16.81(-0.21%)
FTSE 250
20,120.36
-75.59(-0.37%)
AIM
776.04
-4.39(-0.56%)
GBP/EUR
1.1845
-0.0034(-0.29%)
GBP/USD
1.2686
-0.0074(-0.58%)
Bitcoin GBP
52,239.94
+8.94(+0.02%)

How I founded Britain's most respected removals firm

'Doing removals defines you for the rest of your working life'

Tenaya Therapeutics, Inc. (TNYA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

3.3600

-0.3800

(-10.16%)

At close: 04:00PM EDT

3.3400

-0.02

(-0.60%)

After hours:

06:24PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	263.82M
Enterprise value	152.94M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	1.67
Enterprise value/revenue	N/A
Enterprise value/EBITDA	-0.67

Trading information

Stock price history

Beta (5Y monthly)	2.53
52-week change ³	-49.55%
S&P500 52-week change ³	23.76%
52-week high ³	7.0100
52-week low ³	1.6600
50-day moving average ³	4.2748
200-day moving average ³	3.6472

Share statistics

Avg vol (3-month) ³	320.6k
Avg vol (10-day) ³	277.95k
Shares outstanding ⁵	78.52M
Implied shares outstanding ⁶	78.52M
Float ⁸	55.74M
% held by insiders ¹	1.12%
% held by institutions ¹	71.92%
Shares short (15 May 2024) ⁴	3.35M
Short ratio (15 May 2024) ⁴	14.61
Short % of float (15 May 2024) ⁴	6.13%
Short % of shares outstanding (15 May 2024) ⁴	4.27%
Shares short (prior month 15 Apr 2024) ⁴	3.37M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-38.13%
Return on equity (ttm)	-66.69%

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-122.52M
Net income avi to common (ttm)	-124.58M
Diluted EPS (ttm)	-1.6500
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	122.25M
Total cash per share (mrq)	1.56
Total debt (mrq)	11.37M
Total debt/equity (mrq)	7.19%
Current ratio (mrq)	6.72
Book value per share (mrq)	2.02

Cash flow statement

Operating cash flow (ttm)	-100.44M
Levered free cash flow (ttm)	-58.58M